How are refugees supported before and during their studies at the university? An interview with Anna Meier, Head of the Coordination Office for Refugees.
Whether on your bank’s website or your telephone provider’s help line, interactions between humans and chatbots have become part of our daily lives. But do we trust them? And what factors influence our trust? Researchers at the University of Basel recently examined these questions.
Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration, which often leads to vision loss. Their study shows promising results using a precise technique for gene correction.
It’s once again time for one of the most famous stories in the Bible. But what is actually being told – and how? We're joined by theology professor Moisés Mayordomo to take a look at the story of the birth of Jesus and how biblical narratives work.
The University of Basel has a strategic commitment to a family-friendly policy. It has once again received the “audit family-friendly university” certificate. This confirms the university’s family-friendly focus following the first certification in 2021. So it’s a good time to pause and consider: what have we achieved and what do we have planned for the next few years?
How can we ensure that as many Swiss households as possible adopt not only solar panels, but also their own battery to store solar energy, a heat pump, and an electric car? Researchers at the Universities of Basel and Geneva have looked into just this question.
In the TV program “Kassensturz”, two former students reported experiencing sexual harassment from professors and being let down by the university. The Vice President for People & Culture comments on the topic and, together with the Personal Integrity Coordinator, outlines how the university intends to improve its handling of such cases.
Start-up Cimeio Therapeutics intends to pave the way for gentler and more efficient treatments for diseases such as blood cancer. The company, a spin-off of the University of Basel, has just concluded an important collaboration agreement: Cimeio is joining forces with the pharmaceutical firm Kyowa Kirin. Kyowa Kirin will be financing the collaboration with Cimeio with up to CHF 263 million.
Art historian Dr. Charlotte Matter is to become the new assistant professor of contemporary art at the University of Basel. The President’s Office appointed her to the professorship, which is funded by the Laurenz Foundation, within the Faculty of Humanities and Social Sciences.
